IS5183A - A method of enhancing the antineoplastic activity of unprocessed drugs, a mixture that enhances the anti-neoplastic activity of an unprocessed drug, a method of assessing the anti-neoplastic efficacy of the treatment of an unfinished drug, and a method of assessing the anti-tumor efficacy of an unfinished drug. - Google Patents

A method of enhancing the antineoplastic activity of unprocessed drugs, a mixture that enhances the anti-neoplastic activity of an unprocessed drug, a method of assessing the anti-neoplastic efficacy of the treatment of an unfinished drug, and a method of assessing the anti-tumor efficacy of an unfinished drug.

Info

Publication number: IS5183A
Authority: IS; Iceland
Prior art keywords: drug; unfinished; assessing; unprocessed; neoplastic
Prior art date: 1998-09-17

Application number

IS5183A

Other languages

Icelandic (is)

Inventor

Niwa Kozo

Original Assignee

Niwa Kozo

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-17

Filing date

1999-09-17

Publication date

2000-03-17

1999-09-17 Application filed by Niwa Kozo filed Critical Niwa Kozo

2000-03-17 Publication of IS5183A publication Critical patent/IS5183A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/071—Agaricus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Natural Medicines & Medicinal Plants (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Mycology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Biotechnology (AREA)
Alternative & Traditional Medicine (AREA)
Microbiology (AREA)
Botany (AREA)
Medical Informatics (AREA)
Molecular Biology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Hematology (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Immunology (AREA)
Cell Biology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Endocrinology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Medicines Containing Plant Substances (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IS5183A 1998-09-17 1999-09-17 A method of enhancing the antineoplastic activity of unprocessed drugs, a mixture that enhances the anti-neoplastic activity of an unprocessed drug, a method of assessing the anti-neoplastic efficacy of the treatment of an unfinished drug, and a method of assessing the anti-tumor efficacy of an unfinished drug. IS5183A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP26375398		1998-09-17
JP10323374A JP2000159682A (en)	1998-09-17	1998-11-13	Crude drug antitumor activity enhancing method, antitumor activity enhancing crude drug-containing composition, antitumor efficacy evaluating method of crude drug treatment, and antitumor efficacy evaluating method of crude drug

Publications (1)

Publication Number	Publication Date
IS5183A true IS5183A (en)	2000-03-17

Family

ID=26546176

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS5183A IS5183A (en)	1998-09-17	1999-09-17	A method of enhancing the antineoplastic activity of unprocessed drugs, a mixture that enhances the anti-neoplastic activity of an unprocessed drug, a method of assessing the anti-neoplastic efficacy of the treatment of an unfinished drug, and a method of assessing the anti-tumor efficacy of an unfinished drug.

Country Status (19)

Country	Link
JP (1)	JP2000159682A (en)
KR (1)	KR20000023206A (en)
CN (1)	CN1255376A (en)
AU (1)	AU4486299A (en)
BE (1)	BE1012725A5 (en)
CA (1)	CA2282234A1 (en)
DE (1)	DE19944695A1 (en)
DK (1)	DK199901235A (en)
ES (1)	ES2155802B1 (en)
FR (2)	FR2783426A1 (en)
GB (2)	GB9920710D0 (en)
ID (1)	ID23150A (en)
IL (1)	IL131722A0 (en)
IS (1)	IS5183A (en)
IT (1)	IT1307267B1 (en)
NL (2)	NL1013049C2 (en)
NO (1)	NO994463L (en)
SE (2)	SE9903307L (en)
SG (1)	SG76631A1 (en)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2002087603A1 (en) *	2001-04-27	2002-11-07	Ajinomoto Co., Inc.	Immunopotentiators
EP1385970A4 (en) *	2001-05-07	2004-11-24	Biohub Co Ltd	PROCESS FOR THE PREPARATION OF LACTIC FERMENTATION SOLUTION BASED ON FUNGUS AND SOLUTION THUS OBTAINED
JP4499979B2 (en) *	2001-05-21	2010-07-14	コンビ株式会社	Composition for controlling pathogen infection
EP1393738A4 (en) *	2001-06-01	2004-11-17	Ajinomoto Kk	ANTIDIABETIC TREATMENT
JP4826696B2 (en) *	2003-04-07	2011-11-30	ビーエイチエヌ株式会社	Angiogenesis inhibitors
JP4681801B2 (en) *	2002-05-15	2011-05-11	ビーエイチエヌ株式会社	Angiogenesis inhibitor and method for producing the same
US7977379B2 (en)	2002-05-15	2011-07-12	Bhn Co., Ltd.	Method for angiogenesis inhibition or immunostimulation
JP2005089417A (en) *	2003-09-19	2005-04-07	Noevir Co Ltd	Composition for prevention/treatment of diabetes
JP4587441B2 (en) *	2004-02-12	2010-11-24	株式会社クレハ	Novel diabetes treatment and food
JP5034071B2 (en) *	2004-09-17	2012-09-26	株式会社Ｓ・Ｓ・Ｉ	Kawariharatake extract that suppresses breast cancer
JP2006273835A (en) *	2005-03-04	2006-10-12	Michishi Tani	Malignant tumor therapeutic agent and food and drink containing the same
US20120128856A1 (en) *	2009-07-31	2012-05-24	Ming East-West, Llc	Maitake mushroom coffee
JPWO2011081024A1 (en) *	2009-12-29	2013-05-09	株式会社富士見養蜂園	Umami food and production method thereof
CN106309511A (en) *	2016-08-30	2017-01-11	青海民族大学	Effective part of agaricus gennadii for inhibiting CDC25 enzyme as well as preparation method and application of effective part
CN106333969A (en) *	2016-08-30	2017-01-18	青海民族大学	Agaricus gennadii HDAC1 enzyme inhibition effective part and preparation method and application
US20200397817A1 (en) *	2017-11-30	2020-12-24	SHIEH, Darbin	Method for predicting and modulating susceptibility of cancer cell to programmed cell death
KR102602787B1 (en) *	2020-12-16	2023-11-17	대한민국	Method for increasing the content of physiologically active ingredients and nutrients in Sparassis crispa
KR102646421B1 (en) *	2020-12-16	2024-03-12	대한민국	Method for increasing the content of physiologically active ingredients and nutrients in Grifola frondosa
KR102584680B1 (en) *	2020-12-17	2023-10-06	대한민국	Method for manufacturing tea of Lentinula edodes tea improved physiological activities and nutrition components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS5276413A (en) *	1975-12-18	1977-06-27	Kureha Chem Ind Co Ltd	Production of oncostatic substances
US4177108A (en) *	1977-03-02	1979-12-04	Tetsuro Ikekawa	Process for producing emitanin
DE2842691A1 (en) *	1978-09-30	1980-04-10	Karl Dr Med Theurer	Activation of pharmaceuticals by irradiation - using wavelengths corresp. to absorption maxima of the substance, opt. with the simultaneous application of magnetic field
JPS57206618A (en) *	1981-06-12	1982-12-18	Noda Shiyokukin Kogyo Kk	Preparation of antitumor substance
JPH02203765A (en) *	1989-02-02	1990-08-13	Nippon Beet Sugar Mfg Co Ltd	Food having antitumor function and production thereof
JP3357383B2 (en) *	1991-08-14	2002-12-16	昌宏黒田	Low molecular weight plant composition
JP2955126B2 (en) *	1992-06-22	1999-10-04	笑代丹羽	Pharmaceutical oleaginous preparation, food oleaginous preparation and production method thereof
US6015913A (en) *	1996-09-06	2000-01-18	Mars, Incorporated	Method for producing fat and/or solids from cocoa beans

1998
- 1998-11-13 JP JP10323374A patent/JP2000159682A/en active Pending
1999
- 1999-08-31 SG SG1999004406A patent/SG76631A1/en unknown
- 1999-08-31 AU AU44862/99A patent/AU4486299A/en not_active Abandoned
- 1999-09-02 IL IL13172299A patent/IL131722A0/en unknown
- 1999-09-03 GB GBGB9920710.2A patent/GB9920710D0/en not_active Ceased
- 1999-09-03 DK DK199901235A patent/DK199901235A/en not_active Application Discontinuation
- 1999-09-13 GB GB9921387A patent/GB2341800A/en not_active Withdrawn
- 1999-09-14 IT IT1999TO000784A patent/IT1307267B1/en active
- 1999-09-15 NL NL1013049A patent/NL1013049C2/en not_active IP Right Cessation
- 1999-09-15 NO NO994463A patent/NO994463L/en not_active Application Discontinuation
- 1999-09-16 FR FR9911586A patent/FR2783426A1/en not_active Withdrawn
- 1999-09-16 ES ES009902062A patent/ES2155802B1/en not_active Expired - Lifetime
- 1999-09-16 KR KR1019990039799A patent/KR20000023206A/en not_active Withdrawn
- 1999-09-16 CA CA002282234A patent/CA2282234A1/en not_active Abandoned
- 1999-09-16 SE SE9903307A patent/SE9903307L/en not_active Application Discontinuation
- 1999-09-17 BE BE9900625A patent/BE1012725A5/en not_active IP Right Cessation
- 1999-09-17 IS IS5183A patent/IS5183A/en unknown
- 1999-09-17 CN CN99122136A patent/CN1255376A/en active Pending
- 1999-09-17 ID IDP990871D patent/ID23150A/en unknown
- 1999-09-17 DE DE19944695A patent/DE19944695A1/en not_active Withdrawn
2000
- 2000-03-01 FR FR0002640A patent/FR2788697A1/en not_active Withdrawn
2001
- 2001-01-24 SE SE0100195A patent/SE0100195D0/en not_active Application Discontinuation
2002
- 2002-01-07 NL NL1019705A patent/NL1019705C2/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
NL1013049A1 (en)	2000-03-21
NL1019705C2 (en)	2002-03-26
FR2783426A1 (en)	2000-03-24
JP2000159682A (en)	2000-06-13
NO994463L (en)	2000-03-20
NL1019705A1 (en)	2002-01-29
CA2282234A1 (en)	2000-03-17
DK199901235A (en)	2000-03-18
ES2155802B1 (en)	2001-12-01
GB9920710D0 (en)	1999-11-03
NL1013049C2 (en)	2002-01-11
GB2341800A (en)	2000-03-29
CN1255376A (en)	2000-06-07
SE9903307L (en)	2000-03-18
AU4486299A (en)	2000-03-30
SE0100195L (en)	2001-01-24
ITTO990784A0 (en)	1999-09-14
SE0100195D0 (en)	2001-01-24
BE1012725A5 (en)	2001-02-06
DE19944695A1 (en)	2000-03-30
FR2788697A1 (en)	2000-07-28
SE9903307D0 (en)	1999-09-16
ITTO990784A1 (en)	2001-03-14
NO994463D0 (en)	1999-09-15
KR20000023206A (en)	2000-04-25
GB9921387D0 (en)	1999-11-10
ID23150A (en)	2000-03-23
SG76631A1 (en)	2000-11-21
IT1307267B1 (en)	2001-10-30
ES2155802A1 (en)	2001-05-16
IL131722A0 (en)	2001-03-19

Similar Documents

Publication	Publication Date	Title
IS5183A (en)	2000-03-17	A method of enhancing the antineoplastic activity of unprocessed drugs, a mixture that enhances the anti-neoplastic activity of an unprocessed drug, a method of assessing the anti-neoplastic efficacy of the treatment of an unfinished drug, and a method of assessing the anti-tumor efficacy of an unfinished drug.
WO2003090695A3 (en)	2004-05-06	TREATMENT OF α-GALACTOSIDASE A DEFICIENCY
Antman et al.	2005	Enoxaparin versus unfractionated heparin as antithrombin therapy in patients receiving fibrinolysis for ST-elevation myocardial infarction. Design and rationale for the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25)
NO20004654D0 (en)	2000-09-18	Gastroprotected omeprazole microgranules, method for obtaining such and pharmaceutical preparations
NO20052410D0 (en)	2005-05-13	Water-soluble iron carbobrate complexes, their production and drugs containing these complexes
PL362690A1 (en)	2004-11-02	Combinations of drugs (e.g., chlorpromazine and pentamidine) for the treatment of neoplastic disorders
ZA200407813B (en)	2005-10-18	Medicament for preventing and/or treating chronic rejection.
ZA200206612B (en)	2004-02-19	Treatments for female sexual dysfunction and methods for identifying compounds useful for treating female sexual dysfunction.
DE69838638D1 (en)	2007-12-13	IC-MODULE, ITS MANUFACTURING METHOD AND IC-CARD THEREFORE PROVIDED
DK1066056T4 (en)	2009-04-14	Iron dextran compound for use as a component of a therapeutic agent for the prevention or treatment of iron deficiency, method of preparing the iron dextran compound and use of this compound for the manufacture of an ...
NO20033440D0 (en)	2003-08-01	Treatment of neurological dysfunction including fructopyranose sulfamates and erythropoietin
WO2004089296A3 (en)	2006-03-09	Improved inhibitors for the soluble epoxide hydrolase
IS6202A (en)	2001-12-14	Pharmaceutical recipes and methods for administering morphine noses
MXPA03003632A (en)	2003-09-10	METHOD FOR TUMOR TREATMENT USING COMBINATION THERAPY.
CY2367B1 (en)	2004-06-04	Swallow tablet comprising paracetamol.
MXPA03008582A (en)	2003-12-08	Agents and methods for treatment of cancer.
DK1627631T3 (en)	2012-04-30	Morphine sulfate microgranules, process for their preparation and preparation comprising the same
RU2003102402A (en)	2004-07-27	METHOD FOR FORMING BILATERAL ENCLOSURE Pancreatoenteroanastomosis After Medial Pancreatic Resection
IS5809A (en)	2001-01-12	Concomitant administration of ACAT and MMP inhibitors for the treatment of fat degeneration
MXPA02002565A (en)	2003-10-14	Processes for making protein hydrolysates from animal peptone and for preserving mucosa.
NL1017117A1 (en)	2001-07-19	A method of enhancing the anti-tumor activity of an amygdaline-containing material, a composition containing an enhanced amygdaline-containing material, a method of evaluating the anti-tumor effectiveness of a treatment of amygdaline-containing material, and a method of evaluating amygdaline-containing anti-tumor material.
MXPA03006157A (en)	2003-09-16	Hormone replacement therapy method and its administration form.
IS5621A (en)	2000-09-08	Fish feed for farming, form of combination, and method of administration
ZA200402285B (en)	2005-06-13	Ophthalmologic treatment methods using selective iNOS inhibitors.
EP1581759A4 (en)	2006-08-02	Methods for treating taxol-induced sensory neuropathy